BranchOut Food (NASDAQ:BOF – Get Free Report)‘s stock had its “sell (e+)” rating restated by analysts at Weiss Ratings in a report issued on Tuesday,Weiss Ratings reports.
Separately, Wall Street Zen lowered BranchOut Food from a “hold” rating to a “sell” rating in a report on Saturday, August 16th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has an average rating of “Sell”.
Get Our Latest Stock Report on BOF
BranchOut Food Trading Up 1.5%
BranchOut Food (NASDAQ:BOF – Get Free Report) last posted its quarterly earnings results on Wednesday, August 13th. The company reported ($0.17) EPS for the quarter. BranchOut Food had a negative return on equity of 187.09% and a negative net margin of 51.87%.The company had revenue of $3.30 million for the quarter.
Institutional Trading of BranchOut Food
An institutional investor recently bought a new position in BranchOut Food stock. Evernest Financial Advisors LLC acquired a new stake in BranchOut Food Inc. (NASDAQ:BOF – Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 157,000 shares of the company’s stock, valued at approximately $386,000. Evernest Financial Advisors LLC owned 1.64% of BranchOut Food at the end of the most recent quarter. Institutional investors and hedge funds own 2.59% of the company’s stock.
BranchOut Food Company Profile
BranchOut Food Inc develops, markets, sells, and distributes plant-based dehydrated fruit and vegetable snacks, and powders in the United States. The company offers dehydrated fruit and vegetable-based snacks, including avocado chips, chewy banana bites, pineapple chips, brussels sprout crisps, and bell pepper crisps; avocado, banana, and blueberry powders; and industrial ingredients, such as bulk avocado powder, dried avocado pieces, and other fruit powders/pieces.
Featured Stories
- Five stocks we like better than BranchOut Food
- Most Volatile Stocks, What Investors Need to Know
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- Quiet Period Expirations Explained
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for BranchOut Food Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BranchOut Food and related companies with MarketBeat.com's FREE daily email newsletter.